info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Dimethyl Fumarate (Tecfidera)
503
Article source: Seagull Pharmacy
Oct 28, 2025

Dimethyl Fumarate (Tecfidera) is an oral medication approved by the U.S. FDA for the treatment of relapsing forms of multiple sclerosis (MS). As a delayed-release capsule, it regulates the immune response through a unique pharmacological mechanism.

Indications for Dimethyl Fumarate (Tecfidera)

Primary Indications

Dimethyl Fumarate is indicated for the treatment of relapsing multiple sclerosis (RMS) in adults.

Clinically Isolated Syndrome (CIS).

Relapsing-Remitting Multiple Sclerosis (RRMS).

Active Secondary Progressive Multiple Sclerosis (SPMS).

Key Instructions

Patient Selection: Patients must be clearly diagnosed with the aforementioned relapsing forms of MS; it is not indicated for primary progressive multiple sclerosis (PPMS).

Age Restriction: The safety and efficacy of this medication in patients under 18 years of age have not been established.

Treatment Goals: Reduce the frequency of clinical relapses and the activity of MRI lesions, and delay the progression of disability.

Dosage Forms and Characteristics of Dimethyl Fumarate (Tecfidera)

120mg Capsules

Appearance: Green cap and white body, with black printing of "BG12 120mg" on the capsule body.

Use: Initial dose for the first 7 days of treatment (1 capsule twice daily).

240mg Capsules

Appearance: Fully green capsule body, with black printing of "BG-12 240mg" on it.

Use: Maintenance dose starting from day 8 (1 capsule twice daily).

Dosage Form Features

Delayed-Release Technology: Ensures the active ingredient is released in the intestinal tract, reducing gastric irritation.

Administration Requirement: Swallow the capsule whole; do not chew, crush, or sprinkle the contents on food.

Storage Methods for Dimethyl Fumarate (Tecfidera)

Temperature Requirement

Store at 15°C to 30°C (59°F to 86°F). Avoid freezing or exposure to high temperatures (e.g., inside a car, bathroom).

Light and Moisture Protection

Keep the capsules in their original bottle to avoid exposure to light and humid environments.

The desiccant inside the bottle must be retained; do not remove or ingest it.

Safe Storage

Store in a place out of the reach of children and pets, and use child-resistant bottle caps.

Handling of Special Cases: If the capsules change color, become damaged, or the desiccant container swells, discard the product immediately and contact a pharmacist.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Dimethyl Fumarate (Tecfidera)
Dimethyl Fumarate (Tecfidera) is a prescription medication used to treat relapsing forms of multiple sclerosis (MS), with its main active ingredient being dimethyl fumarate. As a specialized therapeut...
What Are the Side Effects of Voranigo?
Voranigo is a targeted therapeutic drug for IDH1/2-mutant low-grade gliomas (grade 2 astrocytomas or oligodendrogliomas). As a new type of isocitrate dehydrogenase inhibitor, its efficacy has been ver...
Precautions for Voranigo Administration
Voranigo is a new type of isocitrate dehydrogenase-1/2 (IDH1/2) inhibitor, indicated for the treatment of patients aged over 12 years with IDH1/2-mutant grade 2 astrocytoma or oligodendroglioma.Precau...
How to Use Voranigo
Voranigo is an isocitrate dehydrogenase-1/2 (IDH1/2) inhibitor, indicated for the treatment of patients aged 12 years and older with IDH1/2-mutant grade 2 astrocytoma or oligodendroglioma.How to Use V...
Precautions for Dimethyl Fumarate (Tecfidera) Administration
Dimethyl Fumarate (Tecfidera) is an oral medication used to treat relapsing forms of multiple sclerosis (MS). It is indicated for adult patients with clinically isolated syndrome, relapsing-remitting ...
What Are the Side Effects of Dimethyl Fumarate (Tecfidera)?
Dimethyl Fumarate (Tecfidera) is an oral medication used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary ...
How to Purchase Nilotinib
Nilotinib (trade name: Tasigna®) is a targeted drug used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+CML). Due to its specific indications and potential severe s...
How to Use Nilotinib
Nilotinib is an inhibitor that targets the Bcr-Abl kinase, primarily indicated for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML) who are resistan...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved